Publisher
Springer Berlin Heidelberg
Reference97 articles.
1. Araga S, LeBoeuf RD, Blalock JE (1993) Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor. Proc Natl Acad Sci USA 90:8747–8751
2. Araga S, Galin FS, Kishimoto M, Adachi A, Blalock JB (1996) Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors. J Immunol 157:386–392
3. Araga S, Xu L, Nakashima K, Villain M, Blalock JE (2000) A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help. FASEB J 14:185–196
4. Attanasio R, Kennedy RC, Allan JS, Maino VC, Buck D, Kanda P (1990) Anti-idiotypic antibodies of a predefined specificity generated against CDR3VH synthetic peptides define a private anti-CD4 idiotype. Mol Immunol 27:513–522
5. Barnaba V, Watts C, de Boer M, Lane P, Lanzavecchia A (1994) Professional presentation of antigen by activated human T cells. Eur J Immunol 24:71–75